---
title: "Top 5 HK Stock Gainers/Losers (>100B) (6.3)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288541442.md"
description: "YOFC(06869) rose 10.65%, with a trading turnover 7.7 Billion HKD, and a year-to-date rose 398.3%. KB LAMINATES(01888) rose 9.55%, with a trading turnover 3.2 Billion HKD, and a year-to-date rose 311.3%. HENGRUI PHARMA(01276) fell 7.05%, with a trading turnover 696.8 Million HKD, and a year-to-date fell 23%. WUXI BIO(02269) fell 7%, with a trading turnover 1.5 Billion HKD, and a year-to-date rose 3.9%."
datetime: "2026-06-03T08:30:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288541442.md)
  - [en](https://longbridge.com/en/news/288541442.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288541442.md)
---

# Top 5 HK Stock Gainers/Losers (>100B) (6.3)

Hang Seng Index has fell 1.56%, with a year-to-date rose 0%; Hang Seng TECH Index has fell 2.74%, with a year-to-date fell 8.3%.

YOFC(06869) rose 10.65%, with a trading turnover 7.7 Billion HKD, and a year-to-date rose 398.3%.

KB LAMINATES(01888) rose 9.55%, with a trading turnover 3.2 Billion HKD, and a year-to-date rose 311.3%.

HENGRUI PHARMA(01276) fell 7.05%, with a trading turnover 696.8 Million HKD, and a year-to-date fell 23%.

WUXI BIO(02269) fell 7%, with a trading turnover 1.5 Billion HKD, and a year-to-date rose 3.9%.

### Related Stocks

- [06869.HK](https://longbridge.com/en/quote/06869.HK.md)
- [01888.HK](https://longbridge.com/en/quote/01888.HK.md)
- [06809.HK](https://longbridge.com/en/quote/06809.HK.md)
- [00501.HK](https://longbridge.com/en/quote/00501.HK.md)
- [02513.HK](https://longbridge.com/en/quote/02513.HK.md)
- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [02269.HK](https://longbridge.com/en/quote/02269.HK.md)
- [03690.HK](https://longbridge.com/en/quote/03690.HK.md)
- [09868.HK](https://longbridge.com/en/quote/09868.HK.md)
- [02097.HK](https://longbridge.com/en/quote/02097.HK.md)

## Related News & Research

- [WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year](https://longbridge.com/en/news/288507867.md)
- [Assessing WuXi Biologics (SEHK:2269) Valuation After Its Recent Share Price Momentum Shift](https://longbridge.com/en/news/288940684.md)
- [Xpeng CEO takes helm of robotics unit to drive physical AI transition](https://longbridge.com/en/news/289277391.md)
- [Xpeng scrambles to boost GX SUV production as wait times hit 35 weeks](https://longbridge.com/en/news/288665260.md)
- [How long can the "market dream rate" of AI-modeled stocks last?](https://longbridge.com/en/news/289128430.md)